Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)	B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 2	2026-05-27		NCT06954805

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Jennifer Amengual	2
The Leukemia and Lymphoma Society	22

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Columbia University Irving Medical Center	New York	United States	234
Stanford Medical Center	Stanford	United States	5

Clinical trials